Breast cancer radiotherapy: Controversies and prospectives

Chinese Medical Journal

Volumn 121, Issue 20, 2008, Pages 1957-1959

  Yu, Jin Ming ^a   Wang, Yong Sheng ^a  

^a SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; TRASTUZUMAB;

ADJUVANT THERAPY; AXILLARY LYMPH NODE; BREAST CANCER; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL TRIAL; DISEASE FREE SURVIVAL; EARLY INTERVENTION; EDITORIAL; ESTHETICS; HUMAN; LYMPH NODE METASTASIS; MASTECTOMY; PATIENT SELECTION; PRACTICE GUIDELINE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RECURRENCE RISK; RISK REDUCTION; TREATMENT DURATION; TUMOR VOLUME; BREAST; BREAST TUMOR; FEMALE; PATHOLOGY; RADIATION EXPOSURE; SEGMENTAL MASTECTOMY;

BREAST; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MASTECTOMY; MASTECTOMY, SEGMENTAL;

EID: 58749111092     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200810020-00001     Document Type: Editorial

References (19)

1. Voordeckers M, Van de Steene J, Vinh-Hung V, Storme G. Adjuvant radiotherapy after mastectomy for pT1-pT2 node negative (pN0) breast cancer: is it worth the effect? Radiother Oncol 2003; 68: 227-231.
2. Overgaard M, Nielsen HM, Overgaard J. Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b & c randomized trials. Radiother Oncol 2007; 82: 247-253.
3. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, et al. Effect of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet 2005; 366: 2087-2106.
4. EBCTCG Secretariat, on behalf of EBCTCG. Highlights from the early breast cancer trialists' collaborative group (EBCTCG) 2005-2006 worldwide overview. Breast Cancer Res Treat 2006; 100: s19.
5. Poortmans P. Evidence based radiation oncology: breast cancer. Radiother Oncol 2007; 84: 84-101.
6. Carlson RW, Anderson BO, Burstein HJ. NCCN breast cancer clinical practice guidelines in oncology. Version 1, 2007. Available at: http://www.nccn.org/physician_gls/PDF/breast.pdf. Accessed January 25, 2007.
7. Carlson RW, Allred DC, Anderson BO. NCCN breast cancer clinical practice guidelines in oncology. Version 2, 2008. Available at: http:// www.nccn.org/professionals/physician_gls/PDF/breast.pdf.
8. Sanders ME, Scroggins T, Ampil FL, Li BD. Accelerated partial breast irradiation in early-stage breast cancer. J Clin Oncol 2007; 25: 996-1002.
9. American Society of Breast Surgeon. Consensus statement for accelerated partial breast irradiation. http://www.breastsurgeons. org/ officialstmts/officialstmt3.shtml.
10. American Brachytherapy Society. Guidelines for accelerated partial breast irradiation. http://www.americanbrachytherapy. org/resources/ healthapps.cfm.
11. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effect of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials. Lancet 2005; 365: 1687-1717.
12. Recht A. Integration of systemic therapy and radiation therapy for patients with early-stage breast cancer treated with conservative surgery. Clin Breast Cancer 2003; 4: 104-113.
13. Bellon JR, Come SE, Gelman RS, Henderson IC, Shulman LN, Silver BJ, et al. Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trial. J Clin Oncol 2005; 23: 1934-1940.
14. Bellon JR, Harris JR. Chemotherapy and radiation therapy for breast cancer: what is the optimal sequence? J Clin Oncol 2005; 23: 5-7.
15. Goldhirsch A, Wood WC, Gelber RD, Coates AS, Thürlimann B, Senn HJ, et al. Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol 2007; 18: 1133-1144.
16. Recht A, Edge SB, Solin LJ, Robinson DS, Estabrook A, Fine RE, et al. Postmastectomy radiotherapy: guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001; 19: 1539-1569.
17. Buchholz TA, Tucker SL, Masullo L, Kuerer HM, Erwin J, Salas J, et al. Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiation. J Clin Oncol 2002; 20: 17-23.
18. Huang EH, Strom EA, Perkins GH. Comparison of risk of local-regional recurrence after mastectomy or breast conservation therapy for patients treated with neoadjuvant chemotherapy and radiation stratified according to a prognostic index score. Int J Radiat Oncol Biol Phys 2006; 66: 352-357.
19. Buzdar AU, Ibrahim NK, Francis D, Booser DJ, Thomas ES, Theriault RL, et al. Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer. J Clin Oncol 2005; 23: 3676-3685.